West Oak Capital LLC Sells 355 Shares of Cardinal Health, Inc. (NYSE:CAH)

West Oak Capital LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 45.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 425 shares of the company’s stock after selling 355 shares during the quarter. West Oak Capital LLC’s holdings in Cardinal Health were worth $50,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Graypoint LLC grew its position in shares of Cardinal Health by 76.8% in the 4th quarter. Graypoint LLC now owns 4,208 shares of the company’s stock worth $498,000 after buying an additional 1,828 shares during the last quarter. Birch Capital Management LLC boosted its position in shares of Cardinal Health by 1.5% in the 4th quarter. Birch Capital Management LLC now owns 28,822 shares of the company’s stock worth $3,409,000 after purchasing an additional 429 shares in the last quarter. Insight Wealth Strategies LLC grew its stake in Cardinal Health by 1.6% during the 4th quarter. Insight Wealth Strategies LLC now owns 19,796 shares of the company’s stock worth $2,341,000 after buying an additional 313 shares during the last quarter. CWA Asset Management Group LLC increased its position in Cardinal Health by 10.1% during the 4th quarter. CWA Asset Management Group LLC now owns 129,052 shares of the company’s stock valued at $15,263,000 after buying an additional 11,847 shares in the last quarter. Finally, Pensionfund Sabic raised its stake in Cardinal Health by 42.0% in the fourth quarter. Pensionfund Sabic now owns 14,200 shares of the company’s stock valued at $1,679,000 after buying an additional 4,200 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Cardinal Health stock traded down $0.83 during trading on Friday, reaching $121.70. The company had a trading volume of 1,974,292 shares, compared to its average volume of 2,267,382. The firm’s 50-day simple moving average is $119.77 and its 200 day simple moving average is $110.84. The firm has a market capitalization of $29.45 billion, a PE ratio of 23.68, a price-to-earnings-growth ratio of 1.47 and a beta of 0.63. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $126.23.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health’s revenue was down 4.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.73 EPS. Analysts anticipate that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a $0.5056 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.66%. Cardinal Health’s dividend payout ratio is presently 39.30%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CAH. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a report on Tuesday. Mizuho started coverage on Cardinal Health in a report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective on the stock. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and lifted their target price for the stock from $130.00 to $144.00 in a report on Wednesday. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $133.29.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.